RxSight (RXST) Total Debt (2020 - 2023)

RxSight (RXST) has reported Total Debt for 4 consecutive years, with $24.8 million the latest figure, recorded in Q2 2023.

• For the quarter ending Q2 2023, Total Debt fell 40.51% year-over-year to $24.8 million; the trailing twelve-month figure through Jun 2023 stood at $24.8 million (down 40.51% YoY), and the FY2022 full-year result was $40.2 million, up 1.03% from the prior year.
• Total Debt retreated to $24.8 million in Q2 2023 per RXST's latest filing, from $40.3 million in the prior quarter.
• Across five years, Total Debt topped out at $41.8 million in Q3 2022 and bottomed at $24.4 million in Q4 2020.
• Historically, Total Debt has averaged $37.2 million across 4 years, with a median of $39.8 million in 2021.
• The sharpest annual moves came in 2021 and 2023: Total Debt jumped 62.96% in 2021, then slumped 40.51% in 2023.
• Over 4 years, Total Debt stood at $24.4 million in 2020, then surged by 62.96% to $39.8 million in 2021, then advanced by 1.03% to $40.2 million in 2022, then plunged by 38.25% to $24.8 million in 2023.
• According to Business Quant data, Total Debt over the past three periods registered $24.8 million, $40.3 million, and $40.2 million for Q2 2023, Q1 2023, and Q4 2022 respectively.